VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 87 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $117,000 | -94.1% | 11,830 | -84.5% | 0.01% | -98.7% |
| Q4 2018 | $1,991,000 | +680.8% | 76,204 | +318.2% | 0.56% | +704.3% |
| Q1 2017 | $255,000 | -1.9% | 18,223 | +11.8% | 0.07% | -6.8% |
| Q4 2016 | $260,000 | -11.3% | 16,296 | -39.0% | 0.07% | -11.9% |
| Q3 2013 | $293,000 | -78.2% | 26,733 | -84.0% | 0.08% | -79.8% |
| Q2 2013 | $1,346,000 | – | 166,634 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Signpost Capital Advisors, LP | 1,688,952 | $27,327,000 | 10.37% |
| Palo Alto Investors LP | 3,240,424 | $52,430,000 | 3.90% |
| Parametrica Management Ltd | 12,509 | $202,000 | 1.53% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,740,400 | $28,160,000 | 1.08% |
| PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 557,100 | $9,014,000 | 1.07% |
| Westend Capital Management, LLC | 64,086 | $841,000 | 1.00% |
| WALL STREET ASSOCIATES | 702,700 | $11,370,000 | 0.98% |
| Baker Brothers Advisors | 4,372,153 | $70,741,000 | 0.87% |
| Iguana Healthcare Management, LLC | 100,000 | $1,618,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,085,301 | $17,560,000 | 0.71% |